19 daysTime to First Decision

Journal of Nanotheranostics, Volume 2, Issue 4

December 2021 - 3 articles

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (3)

Select all

Review

12 Citations

8,636 Views

45 Pages

The Nanotheranostic Researcher’s Guide for Use of Animal Models of Traumatic Brain Injury

Brandon Z. McDonald,
Connor C. Gee and
Forrest M. Kievit

J. Nanotheranostics2021, 2(4), 224-268;https://doi.org/10.3390/jnt2040014

6 December 2021

Traumatic brain injury (TBI) is currently the leading cause of injury-related morbidity and mortality worldwide, with an estimated global cost of USD 400 billion annually. Both clinical and preclinical behavioral outcomes associated with TBI are hete...

Full Article

Review

1 Citations

4,018 Views

16 Pages

Prospects of Extracellular Vesicles in Otorhinolaryngology, Head and Neck Surgery

Metka Sluga,
Saba Battelino and
Domen Vozel

J. Nanotheranostics2021, 2(4), 208-223;https://doi.org/10.3390/jnt2040013

28 November 2021

The diagnostic and therapeutic potential of extracellular vesicles (EVs) has been recognised in many fields of medicine for several years. More recently, it has become a topic of increasing interest in otorhinolaryngology, head and neck surgery (ORL-...

Full Article

Communication

12 Citations

4,777 Views

12 Pages

Surface Adsorption of the Alpha-Emitter Astatine-211 to Gold Nanoparticles Is Stable In Vivo and Potentially Useful in Radionuclide Therapy

Emanuel Sporer,
Christian B. M. Poulie,
Sture Lindegren,
Emma Aneheim,
Holger Jensen,
Tom Bäck,
Paul J. Kempen,
Andreas Kjaer,
Matthias M. Herth and
Andreas I. Jensen

J. Nanotheranostics2021, 2(4), 196-207;https://doi.org/10.3390/jnt2040012

1 October 2021

Targeted α-therapy (TAT) can eradicate tumor metastases while limiting overall toxicity. One of the most promising α-particle emitters is astatine-211 (211At). However, 211At-carbon bonds are notoriously unstable in vivo and no chelators are availabl...

Full Article

Get Alerted

Add your email address to receive forthcoming issues of this journal.

J. Nanotheranostics - ISSN 2624-845X

Imprint

Download Flyer